Clinical Trial Update: BioMIND (Biomarkers for the Molecular Identification of Neurodegenerative Dementia) - Improving Access to Alzheimer's Disease Diagnostics: A Pragmatic System Level Intervention

View source ↗

Summary

This entry documents the BioMIND trial focused on biomarkers for identifying neurodegenerative dementia, aiming to improve access to Alzheimer's disease diagnos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Alzheimer Disease (AD) | Status: NOT_YET_RECRUITING